France revises its stance and approves the AstraZeneca–Oxford vaccine for the over-65s.
MarketWatch.com - Top Stories, MarketWatch
Tue, 03/02/2021 - 7:01am
France revises its stance and approves the AstraZeneca–Oxford vaccine for the over-65s.